Evidence map›Paper›PMID 36051868›Full record

ArticleComputational and structural biotechnology journal2022

Genetically predicted telomere length and its relationship with neurodegenerative diseases and life expectancy.

Blanca Rodríguez-Fernández, Juan Domingo Gispert, Roderic Guigo, Arcadi Navarro, Natalia Vilor-Tejedor, Marta Crous-Bou

Open access · goldAbstract read
In one paragraph

Article in Computational and structural biotechnology journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 27 citations in OpenAlex.

  1. Does Methadone AffectBalkan medical journal · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Observational
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 3 countries.

Blanca Rodríguez-FernándezBarcelonaβeta Brain Research Center - Pasqual Maragall Foundation, Barcelona, Spain.
Juan Domingo GispertBarcelonaβeta Brain Research Center - Pasqual Maragall Foundation, Barcelona, Spain.
Roderic GuigoCentre for Genomic Regulation (CRG), The Barcelona Institute for Science and Technology, Barcelona, Spain.
Arcadi NavarroBarcelonaβeta Brain Research Center - Pasqual Maragall Foundation, Barcelona, Spain.
Natalia Vilor-TejedorBarcelonaβeta Brain Research Center - Pasqual Maragall Foundation, Barcelona, Spain.
Marta Crous-BouBarcelonaβeta Brain Research Center - Pasqual Maragall Foundation, Barcelona, Spain.
Universitat Pompeu Fabra · ESHarvard University · USInstitució Catalana de Recerca i Estudis Avançats · ESPasqual Maragall Foundation · ESSpanish National Centre for Cardiovascular Research · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Telomere length (TL) is a biomarker of biological aging. Shorter telomeres have been associated with mortality and increased rates of age-related diseases. However, observational studies are unable to conclude whether TL is causally associated with those outcomes. Mendelian randomization (MR) was developed for assessing causality using genetic variants in epidemiological research. The objective of this study was to test the potential causal role of TL in neurodegenerative disorders and life expectancy through MR analysis. Summary level data were extracted from the most recent genome-wide association studies for TL, Alzheimer's disease (AD), Parkinson's disease, Frontotemporal dementia, Amyotrophic Lateral Sclerosis, Progressive Supranuclear Palsy and life expectancy. MR estimates revealed that longer telomeres inferred a protective effect on risk of AD (OR = 0.964; adjusted p-value = 0.039). Moreover, longer telomeres were significantly associated with increased life expectancy (

Indexed as

AD, Alzheimer’s diseaseALS, Amyotrophic lateral sclerosisAlzheimer’s diseaseCI, Confidence IntervalFTD, Frontotemporal dementiaGWAS, Genome-wide association studyIV, Instrumental VariableIVW, Inverse-Variance WeightedLife expectancyLRRC34, Leucine Rich Repeat Containing 34Mendelian randomizationMR, Mendelian RandomizationMR-PRESSO, MR-Pleiotropy RESidual Sum and OutlierNeurodegenerative diseasesOR, Odds ratioPD, Parkinson’s diseasePSP, Progressive Supranuclear PalsySE, Standard ErrorSNP, Single Nucleotide PolymorphismTelomere lengthTL, Telomere length

Identifiers

PMID36051868
PMCPMC9399257
OpenAlexW4290052615

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.